Selected Publications
Exploring the Impact of Type 2 Diabetes and Glucose-Lowering Drugs on Gut Microbiome Dynamics
Springer Nature Discover Medicine
Impact Factor: 5.2
This study investigates the complex relationship between type 2 diabetes, glucose-lowering medications, and gut microbiome composition, identifying significant microbial shifts associated with disease progression and treatment.
Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis
Journal of Translational Medicine
Impact Factor: 6.7
This research employs advanced bioinformatics approaches to identify gut microbial genetic variants associated with immunotherapy response in non-small cell lung cancer patients, providing potential biomarkers for treatment prediction.